Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Nablus Surgical Center Company PLC as of March 31, 2025 is 4.90 MM.
- The operating income for Nablus Surgical Center Company PLC as of March 31, 2025 is 0.01 MM.
- The net income for Nablus Surgical Center Company PLC as of March 31, 2025 is -0.11 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-03-31 | 4.90 | 0.01 | -0.11 |
2024-12-31 | 4.34 | -0.31 | -0.46 |
2024-09-30 | 4.62 | 0.04 | -0.27 |
2024-06-30 | 4.99 | 0.31 | -0.21 |
2024-03-31 | 5.12 | 0.48 | 0.09 |
2023-12-31 | 5.80 | 0.96 | 0.80 |
2023-09-30 | 6.10 | 1.36 | 0.72 |
2023-06-30 | 6.14 | 1.27 | 0.90 |
2023-03-31 | 6.42 | 1.56 | 1.19 |
2022-12-31 | 6.59 | 1.50 | 1.15 |
2022-09-30 | 6.85 | 1.50 | 1.58 |
2022-06-30 | 6.78 | 1.47 | 1.46 |
2022-03-31 | 6.69 | 1.26 | 1.26 |
2021-12-31 | 6.55 | 1.18 | 1.13 |
2021-09-30 | 5.82 | 0.59 | 0.65 |
2021-06-30 | 5.81 | 0.56 | 0.59 |
2021-03-31 | 5.31 | 0.20 | 0.23 |
2020-12-31 | 5.28 | 0.26 | 0.32 |
2020-09-30 | 5.94 | 0.63 | 0.52 |
2020-06-30 | |||
2020-03-31 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | -0.08 | -0.08 |
2024-06-30 | -0.06 | -0.06 |
2024-03-31 | 0.02 | 0.02 |
2023-12-31 | 0.23 | 0.25 |
2023-09-30 | 0.21 | 0.21 |
2023-06-30 | 0.26 | 0.26 |
2023-03-31 | 0.35 | 0.35 |
2022-12-31 | 0.34 | |
2022-09-30 | 0.46 | 0.46 |
2022-06-30 | 0.42 | 0.42 |
2022-03-31 | 0.36 | 0.36 |
2021-12-31 | 0.33 | |
2021-09-30 | 0.20 | 0.20 |
2021-06-30 | 0.18 | 0.18 |
2021-03-31 | 0.07 | 0.07 |
2020-12-31 | 0.09 | |
2020-09-30 | 0.17 | 0.17 |
2020-06-30 | 0.11 | 0.11 |
2020-03-31 | 0.20 | 0.20 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Nablus Surgical Center Company PLC as of March 31, 2025 is -0.41 MM.
- The cash from investing activities for Nablus Surgical Center Company PLC as of March 31, 2025 is -0.05 MM.
- The cash from financing activities for Nablus Surgical Center Company PLC as of March 31, 2025 is 0.60 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-03-31 | -0.41 | -0.05 | 0.60 |
2024-12-31 | -0.66 | -0.20 | 0.87 |
2024-09-30 | -0.64 | -0.34 | 0.95 |
2024-06-30 | 0.42 | -0.69 | -0.02 |
2024-03-31 | 1.30 | -1.06 | -0.33 |
2023-12-31 | 1.80 | -0.97 | -1.11 |
2023-09-30 | 1.90 | -0.88 | -1.17 |
2023-06-30 | 1.15 | -0.57 | -0.67 |
2023-03-31 | -0.22 | -0.24 | 0.03 |
2022-12-31 | -1.00 | -0.19 | 0.92 |
2022-09-30 | -1.26 | -0.16 | 0.80 |
2022-06-30 | -0.34 | -0.17 | 0.43 |
2022-03-31 | 0.52 | -0.16 | -0.13 |
2021-12-31 | 0.75 | -0.14 | -0.30 |
2021-09-30 | 1.67 | -0.12 | 0.90 |
2021-06-30 | 1.21 | -0.08 | 0.91 |
2021-03-31 | 0.71 | -0.19 | 1.22 |
2020-12-31 | 1.03 | -0.26 | 1.01 |
2020-09-30 | 0.45 | -0.34 | -0.17 |
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Management Effectiveness
- The roa for Nablus Surgical Center Company PLC as of March 31, 2025 is -0.01.
- The roe for Nablus Surgical Center Company PLC as of March 31, 2025 is -0.01.
- The roic for Nablus Surgical Center Company PLC as of March 31, 2025 is -0.03.
- The croic for Nablus Surgical Center Company PLC as of March 31, 2025 is -0.00.
- The ocroic for Nablus Surgical Center Company PLC as of March 31, 2025 is -0.07.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-03-31 | -0.01 | -0.01 | -0.03 | -0.00 | -0.07 |
2024-12-31 | -0.01 | -0.06 | -0.03 | -0.00 | -0.07 |
2024-09-30 | -0.01 | -0.03 | -0.03 | -0.04 | 0.05 |
2024-06-30 | 0.04 | 0.01 | 0.10 | -0.03 | 0.21 |
2024-03-31 | 0.04 | 0.11 | 0.10 | -0.03 | 0.21 |
2023-12-31 | 0.04 | 0.10 | 0.09 | -0.02 | 0.23 |
2023-09-30 | 0.05 | 0.13 | 0.11 | -0.01 | 0.14 |
2023-06-30 | 0.06 | 0.13 | 0.10 | -0.01 | 0.13 |
2023-03-31 | 0.06 | 0.18 | 0.14 | -0.05 | -0.02 |
2022-12-31 | 0.09 | 0.26 | 0.18 | -0.07 | -0.15 |
2022-09-30 | 0.08 | 0.26 | 0.19 | -0.07 | -0.15 |
2022-06-30 | 0.07 | 0.25 | 0.19 | -0.01 | -0.04 |
2022-03-31 | 0.06 | 0.22 | 0.19 | 0.04 | 0.08 |
2021-12-31 | 0.04 | 0.21 | 0.14 | 0.04 | 0.22 |
2021-09-30 | 0.04 | 0.12 | 0.08 | 0.31 | 0.16 |
2021-06-30 | 0.04 | 0.11 | 0.08 | 0.27 | 0.16 |
2021-03-31 | 0.01 | 0.04 | 0.03 | 0.23 | 0.09 |
2020-12-31 | 0.02 | 0.06 | 0.06 | 0.32 | 0.19 |
2020-09-30 | 0.04 | 0.10 | 0.09 | -0.01 | 0.08 |
2020-06-30 | 0.02 | 0.07 | 0.06 | -0.01 | 0.09 |
2020-03-31 | 0.05 | 0.13 | 0.11 | 0.02 | 0.13 |
Gross Margins
- The gross margin for Nablus Surgical Center Company PLC as of March 31, 2025 is 0.74.
- The net margin for Nablus Surgical Center Company PLC as of March 31, 2025 is -0.06.
- The operating margin for Nablus Surgical Center Company PLC as of March 31, 2025 is 0.01.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-03-31 | 0.74 | -0.06 | 0.01 |
2024-12-31 | 0.74 | -0.06 | 0.01 |
2024-09-30 | 0.76 | -0.04 | 0.06 |
2024-06-30 | 0.79 | 0.13 | 0.19 |
2024-03-31 | 0.79 | 0.13 | 0.19 |
2023-12-31 | 0.78 | 0.12 | 0.22 |
2023-09-30 | 0.77 | 0.15 | 0.21 |
2023-06-30 | 0.78 | 0.15 | 0.21 |
2023-03-31 | 0.78 | 0.19 | 0.24 |
2022-12-31 | 0.78 | 0.23 | 0.22 |
2022-09-30 | 0.78 | 0.23 | 0.22 |
2022-06-30 | 0.77 | 0.22 | 0.22 |
2022-03-31 | 0.76 | 0.19 | 0.19 |
2021-12-31 | 0.75 | 0.17 | 0.18 |
2021-09-30 | 0.73 | 0.11 | 0.10 |
2021-06-30 | 0.73 | 0.10 | 0.10 |
2021-03-31 | 0.71 | 0.04 | 0.04 |
2020-12-31 | 0.71 | 0.06 | 0.05 |
2020-09-30 | 0.71 | 0.09 | 0.11 |
2020-06-30 | 0.72 | 0.06 | 0.08 |
2020-03-31 | 0.73 | 0.11 | 0.13 |
Identifiers and Descriptors
Central Index Key (CIK) |